Tag Archives: Qiagen NV

Investor Alert: Qiagen grabs Spanish biotech STAT-Dx in quest for new and better diagnostic tests. My personal take.

The News: Molecular diagnostics company Qiagen NV (Hilden DEU) has agreed to acquire biotech STAT-Dx SL (Barcelona) for up to €153 million–over 3 times the total funding the Spanish company has raised… Read more »

Liquid biopsy for cancer detection catching on fast. You choose: simple blood test, or invasive solid tissue sample?

The News: Until recently, cancer detection depended on invasive solid tissue sampling that didn’t provide a complete picture. Now, a budding cluster biotechs is making it easier to detect cancer… Read more »